🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
To compare outcomes between the CRS group and the control group in patients...
Status
Recruiting
Location
National Cancer Center, Korea
Start Date
2025-09-10
Trial ID
NCT07171528
Treatments Being Tested
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
This is a multicenter, open-label, randomized phase II trial whose aim is t...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2005-05
Trial ID
NCT00424853
To assess the antitumour activity (response rate) in patients with locally ...
Status
Completed
Location
Sanofi-Aventis
Start Date
2002-07
Trial ID
NCT00425191
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Multiple Locations
Start Date
2000-06-07
Trial ID
NCT00544414
This was an open-label, multicenter, single-arm, Phase II trial of bevacizu...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00312728
Treatments Being Tested
This randomized phase III trial studies chemotherapy and bevacizumab to see...
Status
Completed
Location
Northeast Alabama Regional Medical Center
Start Date
2007-07-19
Trial ID
NCT00324805
This study will aims to determine the maximum tolerated dose of CGC-11047 w...
Status
Completed
Location
Rocky Mountain Cancer Centre
Start Date
2006-05
Trial ID
NCT00705874
This study was conducted to compare the activities of erlotinib to that of ...
Status
Terminated
Location
Lovelace Medical Group
Start Date
2006-07
Trial ID
NCT00391586
Treatments Being Tested